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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To evaluate the effects of psychological interventions on healing and prevention of recurrence of DFU.
B A C K G R O U N D
Description of the condition
Diabetes mellitus (DM) refers to a group of metabolic disorders
resulting from defects in insulin secretion or insulin action, or
both, giving rise to chronic hyperglycaemia (elevated blood glu-
cose levels) (ADA 2009). There are two main types of DM: Type
1 (T1DM) usually develops in childhood, or early adulthood, and
is characterised by insulin deficiency as a result of auto-immune
destruction of the insulin-producing beta cells; Type 2 (T2DM)
develops when there is a gradual beta cell destruction and re-
duced insulin secretion, and/or when the insulin produced does
not work effectively (insulin resistance). Over the last decade the
global prevalence of DM has increased substantially in countries
at all income levels, mirroring the worldwide obesity epidemic
(WHO 2016). It is anticipated that almost 600 million people
worldwide will have DM by the year 2035 (IDF 2015).
Diabetic foot disease, characterised by peripheral neuropathy (loss
of sensation in the feet), ischaemia (reduced blood flow to the feet)
and foot ulceration, is a major complication of diabetes. Approx-
imately 50% of people with diabetes will develop peripheral neu-
ropathy, while 15% to 25%will develop foot ulceration during the
course of the disease (Bus 2016). Diabetic foot ulceration (DFU)
can be defined as a full-thickness wound below the ankle in a per-
son with diabetes (Hoogeveen 2015), caused by peripheral neu-
ropathy or ischaemia or both, and consequent trauma to the foot
(Alexiadou 2012). Chronic ulceration can lead to adverse patient
outcomes and complications including sepsis and increased foot
morbidity, which may require distal (digital or transmetatarsal) or
lower limb amputation (above or below knee). The progression
and outcome fromDFU isworsened by neuropathy and ischaemia
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and a myriad of other complications of diabetes such as impaired
immune function, poor tissue oxygenation and defective healing
(Falanga 2005). DFU is considered the most prevalent and costly
of all diabetes complications and is associated with a five-yearmor-
tality rate of 50% (Armstrong 2011).
The cost of treating DFU poses a significant economic burden.
The EURODIALE study found the estimated costs associated
with treatment of DFU to be EUR 10 billion per year in Europe
(Schaper 2012). In the UK, DFU is estimated to account for 20%
of the total cost of diabetes care (Wounds International Expert
Working Group 2013). DFU also poses significant personal costs
for individuals.
There is a higher risk for ulceration and re-ulceration in men
(Iverson 2008). The underlying cause of this may be associated
with different effects of ulcerationonmale behavioural, emotional,
cognitive and social influences which effect healing and prevention
of DFU recurrence (Vedhara 2012). Gender differences were seen
in a meta-analysis of the effects of psychological interventions in
cardiac patients, suggesting that gender-tailored programmes need
to be developed and evaluated (Linden 2007).
Depression is common in DFU and the prevalence is double that
of the non-diabetic population (Ali 2006; Anderson 2001; Pearson
2014). The evidence to date suggests a bi-directional relationship:
depression is associated with increased risk of T2DM (Nouwen
2010), and the onset of diabetes is associated with subsequent de-
pression (Mezuk 2008), poor glycaemic control (Lustman 2000)
and diabetic complications (De Groot 2001). This may be at-
tributed to the physiological stress of living with diabetes, the psy-
chological burden of self-managing diabetes and coping with the
complications of the disease.Depression substantially increases the
risk of DFU in a dose response manner: the greater the depressive
symptoms the greater the risk of DFU (Iverson 2015). We also
know that depression is associated with a two-fold increased risk
of mortality in people with their first DFU at five years (Winkley
2012). Furthermore, the health-related quality of life among pa-
tients with diabetes and foot ulcers is much lower than the general
population across a wide range of domains including restrictions
in daily activities, physical restrictions and lower social function-
ing (Ribu 2007; Winkley 2009). Twenty per cent of people with
severe mental illness have diabetes, usually T2DM, and these peo-
ple and people from other hard-to-reach groups, such as people
with dementia or learning disabilities, are more likely to die pre-
maturely from cardiovascular disease (Brown 2010; NHS Health
Scotland 2004). They are also more likely to be at risk of suffering
from the complications of diabetes such as diabetic foot disease,
as they are less likely to receive adequate support with diabetes
management (Mitchell 2009). However, as awareness is raised of
these inequalities (Holt 2015), more complex interventions, such
as psychological interventions, may be developed to support these
individuals.
The development of a foot ulcer is a sign of progressive disease,
and once present, DFU can prove challenging to heal (Wounds
International Expert Working Group 2013). Strategies associated
with the prevention of DFU and optimal management of active
DFU are key to reducing the burden of diabetic foot disease. Spe-
cialist multidisciplinary teams have been shown to reduce the in-
cidence of ulceration and amputation (Edmonds 1986); however,
despite best practice, many wounds fail to heal and the risk of
recurrence of DFU remains high (Dubsky 2012). Holding certain
beliefs about diabetes, such as an individual viewing themselves as
having control or influence on ulceration, is associated with bet-
ter engagement with self-care in DFU (Vedhara 2014), and has
also been shown to have a significant effect on survival fromDFU
(Vedhara 2016). Healthcare practitioners such as diabetes profes-
sionals and podiatrists need the knowledge, skills and attitudes to
facilitate an empowering approach and better diabetes self-man-
agement. We know that it is possible to train generalist/diabetes
clinicians in psychological techniques to improve glycaemic con-
trol (Alam 2009; McGloin 2015), but it is necessary to establish
the current level of evidence for the effectiveness of psychological
interventions in DFU.
Description of the intervention
Psychological interventions are by nature complex and difficult
to define and precise definitions are frequently missing from in-
tervention studies and reviews (Hodges 2011). New CONSORT
guidelines are beingdeveloped to guide the reporting of psycholog-
ical intervention studies but are as yet unavailable (Mayo-Wilson
2013).
Psychological interventions are those that use ’the therapeutic al-
liance between the patient and therapist to bring about change in
emotional, cognitive and behavioural functioning’ (Ismail 2004
p1589). Psychological interventions are distinct from other types
of intervention such as education or medication. The aim is to
improve the psychological and physical well-being of patients us-
ing a form of communication, often talking therapy, to foster
a supportive relationship in order to promote patient autonomy
and empowerment in the self-management of their chronic condi-
tion (Alam 2009; Kulzer 2007; McGloin 2015). A psychological
intervention includes a psychotherapeutic (improved emotional,
cognitive or behavioural functioning) or psychosomatic mecha-
nism (addressing the stress of having a condition such as dia-
betes) (Goldbeck 2014). Psychological interventions include, for
example, supportive or counselling therapy, cognitive behavioural
strategies (an umbrella term for problem-solving, contract set-
ting, goal setting, self-monitoring of behaviours and enlisting so-
cial support), psychotherapy or psychological techniques such as
motivational interviewing and also newer techniques such as pos-
itive psychology and acceptance commitment therapy, both de-
rived from cognitive behavioural therapy (CBT) (Goldbeck 2014;
Ismail 2004). Despite the breadth of psychological interventions
that might be used in the treatment of DFU in people with di-
abetes, there is no consensus on how such interventions should
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be classified. Psychological treatments may be categorised in a va-
riety of ways including current behaviour change taxonomies or
according to underlying theory.
How the intervention might work
Psychological interventions aim to reduce levels of psychological
distress, including depression or perceived levels of stress of the
individual, a factor that negatively effects wound healing (Ebrecht
2004; Walburn 2009). Chronic stress increases cortisol release
which has an anti-inflammatory effect. This disrupts the normal
functioning of immune cells required for the inflammatory phase
of wound healing and therefore delays wound healing (Ebrecht
2004; Guo 2010; Kiecolt-Glaser 1995; Vileikyte 2007). Psycho-
logical interventions aim to reduce levels of stress or perceived lev-
els of stress, and there is some evidence to suggest that they can
positively impact the rate of wound healing (Weinman 2008).
The response to stress can also result in unhealthy behaviours (Guo
2010). Psychological interventions may help people improve their
levels of confidence in controlling their diabetes and diabetes self-
management and reduce the potential for ulcer recurrence by en-
abling or supporting people tomake lifestyle changes that promote
wound healing, including adequate sleep, physical activity, limb
elevation and offloading, wearing of a total contact cast and appro-
priate footwear, healthy nutrition, reduced alcohol intake, smok-
ing cessation and improved social interaction (Armstrong 2005;
Brown 2012; Guo 2010). Whilst psychological interventions for
people with DFUmay be beneficial, there may be obstacles to im-
plementation, such as a lack of awareness of psychological issues
on the part of health professionals, and this needs to be consid-
ered. For example, some health professionals may not be aware
that psychological problems are more common in diabetes and
that these are associated with adverse outcome. Addressing these
issues may involve additional training and ultimately provide ac-
cess to psychological services.
Why it is important to do this review
A higher rate of ulcer recurrence is associated with poor glycaemic
control and this may reflect poor patient engagement and a lack of
psychological support (Dubsky 2012). Illness beliefs about DFU
have recently been shown to be linked to survival and predict foot
self-care practice in DFU (Vedhara 2014; Vedhara 2016). Psycho-
logical interventions may have the potential to improve self-care
and reduce the morbidity and costs associated with DFU. There
is a need for a systematic review of the evidence on the effective-
ness of psychological interventions in DFU. This will allow people
with DFUs, health care professionals caring for them and those
trying to prevent recurrence to take informed decisions regarding
their implementation.
A number of systematic reviews of psychological interventions
in diabetes have been conducted or are planned (Alam 2009;
Chew 2017; Ismail 2004; Steed 2003), but to our knowledge
no systematic review of psychological interventions in promoting
healing and preventing recurrence of DFU has been completed.
O B J E C T I V E S
To evaluate the effects of psychological interventions on healing
and prevention of recurrence of DFU.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Wewill include published and unpublishedRCTs including quasi-
randomised, cross-over and cluster RCTs. We will only include
cross-over trials that report outcome data at the end of the first
treatment period and prior to cross-over. We will not limit with
respect to language of the report, year or place of publication.
Types of participants
Eligible participants will include people of 18 years or older, in any
care setting, including their own home, with a DFU or a history
of DFU. The diagnosis of DFU will be based on that determined
by trial authors.
Types of interventions
For the purposes of this review, a psychological interventionwill be
considered for inclusion if it meets the following criteria (adapted
from Goldbeck 2014 and Ismail 2004):
• tailored to the individual and includes psychological
interventions with a psychotherapeutic or psychosomatic
mechanism of action. This includes, but is not limited to,
cognitive behavioural therapy, cognitive therapy, psycho-
dynamic therapy, counselling (techniques of goal setting,
problem solving, identifying strengths and barriers, motivational
interviewing), family systems or systemic therapy, and others
such as supportive, relaxation, and biofeedback;
• provided in structured interactions, face to face or via
telephone in individual or group setting, between a participant
and a facilitator;
• provided by facilitators who may or may not have specific
qualifications or training in psychology or psychotherapy;
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• interactions are of any frequency or duration;
• the main target of the psychological intervention is
promoting healing and preventing recurrence of DFU.
The following broad categories will be used to classify the different
types of interventions (Goldbeck 2014):
• cognitive behavioural therapy;
• cognitive therapy;
• psychodynamic therapy;
• counselling;
• family systems or systemic therapy;
• other interventions.
We will exclude studies of the following interventions:
• interventions which rely only on a structured or
unstructured intervention utilising teaching or instructional
approaches providing information related to DFU;
• specific interventions focused on preventing the first
incidence of foot ulceration.
Where data are available, we will undertake the following com-
parisons:
• psychological interventions versus standard care or versus
another psychological intervention or versus education on
healing of DFU;
• psychological interventions versus standard care or versus
another psychological intervention or versus education on
recurrence of DFU.
Types of outcome measures
Primary outcomes
The primary outcome for this review is complete wound healing.
This may be presented in either or both following formats:
• the proportion of wounds completely healed (frequency of
complete healing by group);
• time to complete wound healing (survival data: study-level
data reported as a hazard ratio (HR) with standard error (SE)).
Recurrence will be assessed as:
• time to recurrence (survival data: study-level data reported
as an HR with SE;
• number of recurrences.
We anticipate that trials will have different follow-up times. For
this review we will group the timing of follow-up data at the fol-
lowing time periods: short-term follow-up (up to 12 weeks fol-
lowing treatment); medium-term follow-up (more than 12 weeks
and up to six months after the end of treatment); and long-term
follow-up (longer than six months and less than 12 months after
the end of treatment).
We will include non-censored data, i.e. mean or median time to
healing without survival analysis, if there is an indication that all
participants experienced complete healing during the trial period
but consider these as less robust assessments of these outcomes, and
will not therefore include these data in preparing the ’Summary
of findings’ table(s).
Secondary outcomes
• Amputations (major or minor).
• Health-related quality of life, as measured by tools such as
SF-36 or EQ5D and/or disease-specific quality of life
instruments designed for use with DFU patients.
• Self-efficacy as measured by tools such as the Diabetes
Empowerment Scale and/or the Footcare Confidence Scale.
• Cost.
Search methods for identification of studies
Electronic searches
Wewill search the following electronic databases to identify reports
of relevant studies:
• the Cochrane Wounds Specialised Register (to present);
• the Cochrane Central Register of Controlled Trials
(CENTRAL) in the Cochrane Library (latest issue);
• Ovid MEDLINE (1946 to present);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations, to present);
• Ovid Embase (1974 to present);
• EBSCO CINAHL Plus (1937 to present);
• Ovid PsycINFO (1806 to present).
The provisional search strategy for the Cochrane Central Register
of Controlled Trials (CENTRAL) is presented in Appendix 1. We
will adapt this strategy to search the other databases listed above.
We will combine the Ovid MEDLINE search with the Cochrane
Highly Sensitive Search Strategy for identifying randomised tri-
als in MEDLINE: sensitivity- and precision-maximising version
(2008 revision) (Lefebvre 2011). We will combine the Embase
search with the Ovid Embase randomised trials filter terms devel-
oped by the UK Cochrane Centre (Lefebvre 2011). We will com-
bine the CINAHL Plus search with the randomised trials filter
terms developed by the Scottish Intercollegiate Guidelines Net-
work (SIGN 2017). We will not restrict studies with respect to
language, date of publication or study setting.
We will search the following clinical trials registries to identify
ongoing trials.
• World Health Organization (WHO) International
Clinical Trials Registry Platform (ICTRP);
• ClinicalTrials.gov;
• European Union (EU) Clinical Trials Register.
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Searching other resources
We will try to identify any remaining eligible trials by searching
the reference lists of all included trials, systematic reviews, meta-
analyses and health technology assessment reports.Wewill contact
experts in the area of psychological interventions and DFU, seek-
ing information on studies relevant to the review. We will search
other sources including conference proceedings, dissertation and
theses databases.
Data collection and analysis
The methodology for data collection and analysis is based on the
Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2011).
Selection of studies
Two reviewers (HMG and GG) will independently assess the title
and abstract of all potentially relevant studies identified from the
search strategy to identify those which might meet the inclusion
criteria. We will retrieve the full text of studies identified as poten-
tially relevant by at least one author. The same review authors will
independently screen full text articles for inclusion or exclusion.
We will resolve any disagreement by discussion or, if necessary, we
will consult a third review author (CMI). All studies excluded at
the full text stage will be listed as excluded studies and reasons for
their exclusion will be presented in the ‘Characteristics of excluded
studies’ table. We will report our screening and selection processes
including findings at each stage in an adapted PRISMA flowchart
(Liberati 2009).
Data extraction and management
Two authors (HMG and GG) will independently extract data
using a data extraction form designed specifically for this study.
Any disagreements will be resolved by discussion or, if necessary,
we will consult with a third review author (DD or CMI). We will
extract the following information from each included study:
• trial authors
• year of publication
• country where RCT performed
• setting of care
• unit of investigation - participant, leg or ulcer
• overall sample size
• participant selection criteria
• number of participants randomised to each treatment arm
• baseline characteristics of participants per treatment arm
(gender, age, baseline ulcer area, ulcer duration and previous
history of ulceration)
• details of the psychological intervention including:
intervention content (components, techniques, treatment
materials, tailoring to individual), proposed mechanism of
action, method of delivery, number of sessions, length or time of
session, background, qualifications and training of healthcare
personnel delivering the intervention, target outcome
• duration of treatment
• duration of follow-up
• statistical methods used for data analysis to inform
decisions on whether or not baseline adjustments have been
made and if data are censored
• primary and secondary outcomes measured
• withdrawals (per treatment arm with numbers and reasons)
• source of trial funding.
We will pilot test the data extraction tool on two papers prior to
the conduct of the full review and amend as necessary.
One reviewer (HMG) will enter all data into Review Manager 5
(RevMan 5) software which will be checked for accuracy against
the data extraction sheets by a second reviewer (GG) (Review
Manager 2014). Where additional information is needed, we will
try to contact authors of the original reports to provide further
details.
Assessment of risk of bias in included studies
Two reviewers (HMG and GG) will independently assess each
study for risk of bias using theCochrane ’Risk of bias’ tool (Higgins
2011). This tool assesses risk of bias in sequence generation, al-
location concealment, blinding, attrition, selective reporting and
other topic- or design-specific issues (e.g. extreme baseline imbal-
ance). Any disagreements regarding the risk of bias assessment will
be resolved by discussion or by involving a third author (DD).
The risk of bias for each study across each domain will also be
summarised graphically. Criteria for judgements for each risk of
bias domain are given in Appendix 2.
Risk of bias will be assessed for self-reported and objective outcome
measurement for the two blinding and incomplete outcome data
domains. Where information on risk of bias relates to unpublished
data or correspondence with trialists, this will be noted in the ’Risk
of bias’ table.
Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary rela-
tive risks (RR) with their corresponding 95% confidence intervals
(95% CI).
Continuous data
For continuous data, we will use the mean difference where out-
comes are measured in the same way between trials; and the stan-
dardised mean difference to combine outcomes from trials that
measure the same outcome but use different scales (Higgins 2011).
We will report differences with corresponding 95% CIs. Where
continuous data are reported and baseline and final score are given,
change score data will take precedence.
5Psychological interventions for treating and preventing recurrence of foot ulcers in people with diabetes (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Time to event data
The intervention effect for time-to-event data will be expressed as
a hazard ratio. We will use the methods used to analyse time-to-
event outcomes described byTierney 2007 anddetailed inChapter
7, section 7.7.6. of the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011).
Unit of analysis issues
Cluster randomised trials
If a cluster-randomised trial is included in this review, we will
adjust the sample sizes for all included arms using the methods
described in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011) using an estimate of the intra-cluster
correlation co-efficient (ICC) derived from the trial (where given),
from a similar trial or from a trial of a similar population. If we
use ICCs from other sources, we will report this and conduct sen-
sitivity analyses to investigate the effect of variation in the ICC on
intervention effect estimates.
We will perform a sensitivity analysis to investigate the effects of
the randomisation unit, i.e. to determine the sensitivity of the
effect estimates to inclusion and exclusion of cluster trials.
Studies with multiple arms
For studies with multiple treatment arms, we will combine all
relevant experimental intervention groups in the study (e.g. groups
with psychological interventions of different duration) into a single
group and all comparable relevant control intervention groups into
a single control group. We will not combine control groups with
different types of interventions (e.g. standard care and education
on DFU healing) in a single meta-analysis and will instead analyse
these separately.
Repeated measures
If repeated outcome assessments are presented, we will group as-
sessment time-frames as 12 weeks or less (short term), more than
12 weeks to six months (medium term) and more than 6 to 12
months (long term).
Cross-over trials
We will incorporate outcome data from cross-over trials only at
the end of the first treatment period and prior to cross-over.
Dealing with missing data
We will note levels of attrition for all included trials. We will con-
tact trial authors for missing data and if no response will consider
available data.
We will carry out analyses, as far as possible, on an intention-to-
treat basis, i.e. we will attempt to include all participants in the
group towhich theywere randomised, regardless of whether or not
they received the allocated intervention.The denominator for each
outcome in each trial will be the number of people randomised
minus any for whom outcomes are known to be missing. Where
a randomised participant is not included in the analysis, we will
assume that there is no ulcer healing i.e., the person will contribute
to the denominator only.
Assessment of heterogeneity
We will assess clinical heterogeneity by exploring the variability
of participants, interventions, and comparators and outcomes. In
particular, we will explore the effect of gender and type of psy-
chological approach through subgroup analyses (see ‘Subgroup
analysis and investigation of heterogeneity’). Meta-analysis will
only be conducted if the participants, interventions, and compara-
tors and outcomes are sufficiently homogenous for summary esti-
mates, including average summary estimates, to be meaningful.
We will assess statistical heterogeneity in each meta-analysis using
the I² and Chi² statistics. We will regard statistical heterogeneity
as substantial/considerable if an I² is greater than 50% or if there
is a low P value (less than 0.10) in the Chi² test for heterogeneity.
Where we identify substantial clinical, methodological or statis-
tical heterogeneity across included trials, we will use a narrative
approach to data synthesis.
Assessment of reporting biases
We will comprehensively search multiple databases, online trial
registries and grey literature to locate all relevant publications. If
there are more than 10 studies included in the meta-analysis, a
funnel plot of all studies will be used to visually assess reporting
biases. If we detect funnel plot asymmetry visually, wewill perform
exploratory analyses using the test proposed by Egger 1997 for
continuous outcomes and that proposed by Harbord 2006 for
dichotomous outcomes.
Data synthesis
Details of included studies will be combined in a narrative re-
view according to type of comparator, possibly by location/type
of wound and then by outcomes by time period. Clinical and
methodological heterogeneity will be considered and pooling un-
dertaken when studies appear appropriately similar in terms of
wound type, intervention type, duration of follow-up and out-
come type.
In terms of meta-analytical approach, we are unable to pre-specify
the amount of clinical, methodological and statistical heterogene-
ity in the included studies but it might be extensive. Thus, we an-
ticipate using a random effects approach for meta-analysis. Con-
ducting meta-analysis with a fixed effect model in the presence of
even minor heterogeneity may provide overly narrow confidence
intervals. We will only use a fixed-effect approach when clinical
and methodological heterogeneity is assessed to be minimal, and
the assumption that a single underlying treatment effect is being
estimated holds. Chi-squared and I-squared will be used to quan-
tify heterogeneity but will not be used to guide choice of model for
meta-analysis. We will exercise caution when meta-analysed data
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are at risk of small study effects because a random effects model
may be unsuitable. In this case, or where there are other reasons
to question the selection of a fixed effect or random effects mode,
we will assess the impact of the approach using sensitivity analyses
to compare results from alternate models. We will report any ev-
idence that suggests that the use of a particular model might not
be robust. We may meta-analyse even when there is thought to
be extensive heterogeneity. We will attempt to explore the causes
behind this using meta-regression, if possible (Thompson 1999).
Data will be presented using forest plots where possible. For di-
chotomous outcomes we will present the summary estimate as a
risk ratio (RR) with 95% CI. Where continuous outcomes are
measured in the same way across studies, we plan to present a
pooled mean difference (MD) with 95% CI; we plan to pool stan-
dardised mean difference (SMD) estimates where studies mea-
sure the same outcome using differentmethods. For time-to-event
data, we plan to plot (and, if appropriate, pool) estimates of hazard
ratios and 95% CIs as presented in the study reports using the
generic inverse variance method in RevMan 5.3. Where time to
healing is analysed as a continuous measure but it is not clear if
all wounds healed, use of the outcome in the study will be doc-
umented but data will not be summarised or used in any meta-
analysis.
Pooled estimates of treatment effect will be obtained using
Cochrane RevMan software (version 5.3) (RevMan 2014).
’Summary of findings’ tables
For each comparison, we will prepare a ‘Summary of findings’
table. Two reviewers will independently grade the quality of the
evidence for each outcome using criteria devised by the GRADE
WorkingGroup 2004 andGRADEprofiler (GRADEpro) software
(Guyatt 2008; Higgins 2011; Schünemann 2010). The four lev-
els of evidence quality are ’high’, ’moderate’, ’low’ or ’very low’.
Quality may be downgraded due to study limitations (risk of bias),
imprecision, inconsistency, indirectness or publication bias. We
will include only primary outcomes in the ‘Summary of findings’
table, i.e. the proportion of wounds completely healed and time
to complete wound healing.
Subgroup analysis and investigation of heterogeneity
We expect the following to introduce clinical heterogeneity and
plan to carry out the following subgroup analysis to explore the
impact of treatment approach.
1. Male versus female participants
The rationale for the subgroup analysis between genders is because
it has been suggested that there is a higher risk for ulceration
and re-ulceration in men due to different psychological and social
responses to chronic illness (Iverson 2008). There may be gender
differences in the effects of psychological interventions in DFU.
Exploring these is an important first step to developing gender-
tailored programmes (Linden 2007).
2. Type of psychological approach according to the classification
by Goldbeck 2014. See Types of interventions section.
It is clinically important to understandwhich type of psychological
intervention could be most successful.
We will limit subgroup analyses to primary outcomes and will
explore subgroup differences by interaction tests available within
RevMan 5 including the Chi² statistic and P value, and the inter-
action test I² value (Review Manager 2014).
Sensitivity analysis
A sensitivity analysis will be conducted on use of a fixed versus a
random effects model and on trial quality, by excluding all studies
at high risk of bias in sequence generation and allocation conceal-
ment. We will limit sensitivity analyses to primary outcomes.
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A P P E N D I C E S
Appendix 1. Provisional search strategy for the Cochrane Central Register of Controlled Trials
(CENTRAL)
#1 MeSH descriptor: [Foot Ulcer] explode all trees
#2 MeSH descriptor: [Diabetic Foot] explode all trees
#3 (diabet* near/3 ulcer*):ti,ab,kw
#4 (diabet* near/3 (foot or feet)):ti,ab,kw
#5 (diabet* near/3 wound*):ti,ab,kw
#6 (diabet* near/3 amputat*):ti,ab,kw
#7 (diabet* near/3 defect*):ti,ab,kw
#8 {or #1-#7}
#9 MeSH descriptor: [Behavior and Behavior Mechanisms] explode all trees
#10 MeSH descriptor: [Behavioral Disciplines and Activities] explode all trees
#11 MeSH descriptor: [Psychological Phenomena and Processes] explode all trees
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#12 MeSH descriptor: [Psychology] explode all trees
#13 psycho*:ti,ab,kw
#14 ((cognitive or interpersonal) near/4 therapy):ti,ab,kw
#15 ((Contract or goal) near/4 set*):ti,ab,kw
#16 ((Support and (social or famil* or friend* or profession*)) or counsel* or advic* or advis*):ti,ab,kw
#17 (Motivational near/4 interview*):ti,ab,kw
#18 ((chang* or improv* or increas* or decreas* or reduc* or modif* or activat* or encourag* or train* or educat* or teach* or control*
or manag*) near/4 (emotion* or cogniti* or behaviour* or style or self* or relaxation or stress or anxiety or depress*)):ti,ab,kw
#19 (problem near/4 (solv* or sort* or control* or manag*)):ti,ab,kw
#20 coach*:ti,ab,kw
#21 MeSH descriptor: [Health Education] explode all trees
#22 (patient and (educat* or train* or teach*)):ti,ab,kw
#23 ((patient or health) and literacy):ti,ab,kw
#24 {or #9-#23}
#25 {and #8, #24}
Appendix 2. The Cochrane tool for assessing risk of bias
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process provided to permit a judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: use of an open random allocation schedule (e.g. a list of random numbers); assignment envelopes without appropriate
safeguards (e.g. envelopes were unsealed, non-opaque, or not sequentially numbered); alternation or rotation; date of birth; case record
number; any other explicitly unconcealed procedure.
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Unclear
Insufficient information provided to permit a judgement of low or high risk of bias. This is usually the case if themethod of concealment
is not described, or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is
described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Either of the following.
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data are unlikely to be related to true outcome (for survival data, censoring unlikely to be
introducing bias).
• Missing outcome data are balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is not enough to
have a clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, a plausible effect size (difference in means or standardised difference in means) among missing
outcomes is not enough to have a clinically relevant impact on the observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following.
• Reason for missing outcome data are likely to be related to the true outcome, with either an imbalance in numbers or reasons for
missing data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is enough to induce
clinically relevant bias in the intervention effect estimate.
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• For continuous outcome data, a plausible effect size (difference in means or standardised difference in means) among missing
outcomes is enough to induce a clinically relevant bias in the observed effect size.
• ’As-treated’ analysis done with a substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Either of the following.
• Insufficient reporting of attrition/exclusions to permit a judgement of low or high risk of bias (e.g. number randomised not
stated, no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following.
• The study protocol is available and all of the study’s prespecified (primary and secondary) outcomes that are of interest in the
review have been reported in the prespecified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were prespecified (convincing text of this nature may be uncommon)
High risk of bias
Any one of the following.
• Not all of the study’s prespecified primary outcomes have been reported.
• One or more primary outcomes is/are reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that
were not prespecified.
• One or more reported primary outcomes was/were not prespecified (unless clear justification for their reporting is provided, such
as an unexpected adverse effect).
• One or more outcomes of interest in the review is/are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information provided to permit a judgement of low or high risk of bias. It is likely that the majority of studies will fall into
this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• has been claimed to have been fraudulent; or
• had some other problem.
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Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
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